+1 (202) 780-3397
Short Communication - Journal of Molecular Oncology Research (2021) Volume 5, Issue 3
Cancer response to drug therapy from decades.
Malignant growth chemotherapy has seen a lot of progress since the presentation of nitrogen mustards during the 1940s. Lamentably, singular patients with clearly indistinguishable tumor histologies don't generally react indistinguishably from a similar medication routine. Deciding the affectability and opposition of a living being before treatment has been the norm of care in irresistible illnesses for a long time, while in oncology treatment has been started by tumor histology instead of the tumor's affectability to a given specialist.
Author(s): Takeharu Yamaguchi